We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Board Opts to Keep Current Evaluations Guide for Time Being
NICE Board Opts to Keep Current Evaluations Guide for Time Being
The UK’s health cost watchdog says it is not ready to change the way it appraises medicines and other technologies, but acknowledges that further consideration is needed of how new treatments are developed, evaluated and supported for coverage.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor